Evidence strategy · Oncology · Ageing

Rethinking Age in Oncology

We start with the questions that matter.

Real-world evidence, clinical trials and strategic advisory to optimize the use of cancer medicines in older adults.

Bridging Ageing,
Oncology & Evidence

Older adults are a growing proportion of people living with cancer, yet important evidence gaps remain across clinical development and real-world practice. OmegaOnco brings together scientific expertise, real-world evidence and AI-enabled intelligence to address the questions that matter for older patients.

Our expertise

Evidence built around the decision.

A focused set of capabilities spanning evidence generation, clinical research, strategic advisory and AI-enabled analysis.

01

Real-World Evidence

Generate fit-for-purpose evidence to support clinical, regulatory and access decisions.

02

Clinical Trials

Strengthen evidence generation for older adults across real-world and hybrid research settings.

03

Strategic Advisory

Align evidence, development and lifecycle strategy around the questions that matter.

04

AI-Enabled Evidence Intelligence

Use fit-for-purpose AI-enabled approaches, with expert oversight, to turn complex oncology data into faster, decision-ready evidence.

Better evidence starts with a better question.

Talk to OmegaOnco about an evidence need in older adults with cancer.

Start a conversation